Riskpilot← Back to searchSign inGet full accessADRENALIN AS
ASActiveOrg 982713862Parkveien 20, 5007 BergenBusiness and other management consultancy activities · NACE 7020Est. 20002 employees
Revenue 2024
NOK 5,8M
+52% vs 2023
EBITDA margin
57.4%
+242% vs 2023
Equity ratio
93.9%
Financial strength
Net profit 2024
NOK 2,8M
+406% vs 2023
| Revenue | NOK 5,8M | +52% |
| EBITDA | NOK 3,4M | +242% |
| Net profit | NOK 2,8M | +406% |
| Total assets | NOK 14,8M | +5% |
| Equity | NOK 13,9M | +14% |
| Employees | 2 | — |
Legal name
ADRENALIN AS
Org number
982713862
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
11. desember 2000
Share capital
NOK 110 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. To styremedlemmer i fellesskap.
Company purpose
Tilby konsulenttjenester innen strategi, finans, i forbindelse med omstillings- og omorganiseringsprosesser i næringslivet, konsulenttjenester innenfor reklame og design, produksjon og salg av kunstartikler, eie aksjer og andeler i andre selskaper med tilsvarende formål, samt hva som står i forbindelse hermed.
Address
Parkveien 20, 5007 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 679 | 2 699 | 13 189 | 10 685 | 9 506 | 14 147 | 7 150 | 1 618 | 4 926 | 17 906 | 1 568 | 8 325 | 50 842 | 411 | 3 839 | 5 839 |
| Staff expenses | −1 316 | −1 207 | −1 413 | −1 536 | −1 231 | −1 496 | −1 467 | −1 216 | −1 253 | −1 663 | −1 638 | −1 664 | −1 930 | −1 962 | −2 097 | −2 106 |
| EBITDA | 4 563 | 181 | 11 368 | 8 538 | 8 002 | 12 173 | 5 281 | 25 | 3 377 | 15 719 | −491 | 6 220 | 48 493 | −2 425 | 979 | 3 352 |
| Depreciation & amort. | −26 | −30 | −12 | −20 | −34 | −17 | −5 | −11 | −11 | −6 | −0 | −0 | −35 | −7 | −18 | −18 |
| EBIT | 4 538 | 151 | 11 355 | 8 519 | 7 968 | 12 156 | 5 276 | 14 | 3 365 | 15 713 | −491 | 6 220 | 48 458 | −2 432 | 962 | 3 334 |
| Net financials | −37 | −33 | −4 | 527 | 612 | 984 | 148 | −5 705 | −1 963 | 1 511 | 799 | 1 532 | −474 | 13 415 | −174 | 253 |
| Profit before tax | 4 501 | 118 | 11 352 | 9 046 | 8 580 | 13 140 | 5 424 | −5 692 | 1 402 | 17 224 | 307 | 7 753 | 47 984 | 10 983 | 788 | 3 587 |
| Tax | 1 286 | 53 | 3 189 | 2 430 | 2 279 | 3 355 | 1 446 | −1 144 | 823 | 3 287 | −80 | 1 378 | 10 659 | −432 | 226 | 745 |
| Net profit | 3 214 | 65 | 8 163 | 6 616 | 6 301 | 9 785 | 3 978 | −4 547 | 579 | 13 937 | 387 | 6 375 | 37 325 | 11 415 | 562 | 2 843 |
| Item | 2008 | 2009 | 2010 | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 384 | 2 479 | 14 783 | 11 808 | 10 338 | 16 378 | 16 183 | 9 869 | 9 653 | 24 496 | 18 716 | 19 287 | 45 355 | 12 385 | 14 034 | 14 757 |
| Equity | 641 | 706 | 1 669 | 1 185 | 2 103 | 9 888 | 13 866 | 9 319 | 8 898 | 20 835 | 18 422 | 17 547 | 7 533 | 11 598 | 12 160 | 13 853 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 743 | 1 773 | 13 115 | 10 624 | 8 235 | 6 490 | 2 316 | 549 | 755 | 3 661 | 294 | 1 739 | 37 821 | 787 | 1 874 | 904 |
| Total debt | 5 743 | 1 773 | 13 115 | 10 624 | 8 235 | 6 490 | 2 316 | 549 | 755 | 3 661 | 294 | 1 739 | 37 821 | 787 | 1 874 | 904 |
EBITDA margin
57.4%
This company
15.8%
Market median
+263% vs market
20082024
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20082024
Return on equity
20.5%
This company
18.4%
Market median
+11% vs market
20082024
Net profit margin
48.7%
This company
8.1%
Market median
+501% vs market
20082024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20082024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Chairman | 2000 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ADRENALIN AS 
Saga Corporate Finance AsBoard members of ADRENALIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Bernhard Waage | Board of Directors | 0 companies |
| Lilli-Anne Alver | Board of Directors | 0 companies |
| Ivan Ove Alver | Chairman | 0 companies |